Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02864953 |
|---|---|
| Brief Title: | Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM) |
| First Submitted : | July 12, 2016 |
| First Submitted that Met QC Criteria : | August 9, 2016 |
| First Posted : | August 12, 2016 (Estimate) |
| Results First Submitted : | December 19, 2023 |
| Results First Submitted that Met QC Criteria : | December 19, 2023 |
| Results First Posted : | January 9, 2024 |
| Last Update Submitted that Met QC Criteria : | April 26, 2024 |
| Last Update Posted : | April 30, 2024 |